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OBJECTIVEdCompare differences in health-related quality of life among blacks and whites
to examine if race, diabetes, and visual impairment (VI) present a triple disadvantage in terms of
quality-adjusted life expectancy.
RESEARCHDESIGNANDMETHODSdData were analyzed from the 2000–2003Med-
ical Expenditure Panel Survey, a nationally representative survey that contains the EuroQol 5D
(EQ-5D). The EQ-5D generates health utility values that provide a measure of the morbidity
associated with various health states, such as having moderate or severe problems with mobility.
The EQ-5D score can be linked with life expectancy data to calculate quality-adjusted life-years
(QALYs), the number of years of optimal health an individual is expected to live. Multivariate
analyses were conducted to estimate and compare differences in QALYs by diabetes status, VI
status, and race.
RESULTSdWhites had a higher quality-adjusted life expectancy across all diabetes/VI com-
parisons. Overall, blacks with diabetes and VI had the fewest number of QALYs remaining (19.6
years), andwhites with no impairment had the greatest number of QALYs remaining (31.6 years).
Blacks with diabetes only had 1.7 fewer years of optimal health (fewer QALYs) than whites with
diabetes. Within individuals with both diabetes and VI, however, this gap more than doubled,
with blacks experiencing 3.5 fewer QALYs than whites.
CONCLUSIONSdAlthough efforts to target and reduce racial health disparities associated
with diabetes appear to be effective, black communities may be contributing to a greater overall
burden of illness given poorer infrastructure and less accommodation for disabilities such as VI.
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Compared with the general popula-tion, blacks are disproportionatelyaffected by diabetes and visual im-
pairment (VI). Blacks over the age of 20
years are 1.8 times more likely to have
diabetes compared with non-Hispanic
whites (1), and the overall age-adjusted
rates of VI among African Americans are
twice that of whites (2). Some evidence sug-
gests that diabetes prevention and disease-
management protocols may be helping to
reduce the gap in mortality rates between
blacks and whites (3). There is very
limited evidence, however, examining
whether persistent community factors,
such as a lack of assistive infrastructure
for the visually impaired, limit the gains
that can be made by medicine alone.
Such factors are more of a concern in black
communities and may contribute to a rela-
tively lower quality of life among thosewith
chronic illness and disabilities (4,5). The
current study examines racial disparities
and the burden of diabetes in those with
and without VI using quality-adjusted life-
years (QALYs) as a comprehensivemeasure
of health and longevity. We explore how
race, diabetes, and VI combine to create a
triple disadvantage among blacks.
RESEARCH DESIGN AND
METHODSdData were obtained from
the 2000–2003 Medical Expenditure
Panel Survey (MEPS), a nationally repre-
sentative subsample of the National Health
Interview Survey. The MEPS is an annual
survey of families and individuals, their
medical providers, and employers across
the U.S. (6). In order to have an adequate
number of persons in certain population
subgroups, the MEPS oversampled blacks
and Hispanics in all years and began over-
sampling of Asians in 2002 (7). The sample
for the current analysis is comprised of
40,215 adults, with 2,397 (;6%) report-
ing having only diabetes and 427 (;1%)
reporting both diabetes and VI.
Participants were classified as having
diabetes if they reported being told by a
healthcare provider that they had diabe-
tes. To determine VI status, participants
were asked a set of visual impairment
questions. Their answers were summarized
into a five-category VI status variable: 1, no
difficulty seeing; 2, some difficulty seeing,
can read newsprint; 3, some difficulty
seeing, cannot read newsprint, can rec-
ognize familiar people; 4, some difficulty
seeing, cannot read newsprint, cannot
recognize familiar people, but is not blind;
and 5, blind. In order to preserve a large
enough sample for comparing individuals
with both diabetes and VI, participants
falling into categories 2–5 were combined
into one single category designated as “any
VI.” Sampling weights were applied in
order to ensure that the resulting sample
was nationally representative of the U.S.
population and include adjustment for
oversampling of race/ethnic groups and
survey nonresponse.
In 2000, MEPS added the EuroQol
5D (EQ-5D), a preference-based health
status classification scale that asks par-
ticipants to report the degree of problems
(none,mild, and severe) encountered across
five domains: mobility, self-care, daily
activities, pain, and anxiety/depression.
EQ-5D generates a health-related quality
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of life (HRQL) score between 0 (death) and
1 (perfect health), using U.S. health utility
preference weights (8). For the purposes of
illustration, consider a person in otherwise
perfect health who cannot walk because of
diabetes-related complications and who
has a HRQL score of 0.6. This indicates
that for the average person who cannot
walk but is in otherwise perfect health,
each year of life lived is valued at 60% of
that of a personwho can fullywalk (9). This
HRQL score can be used to multiply the
average life expectancy for an individual
(based on age, sex, race, and disease status)
to determine the adjusted number of re-
maining years of perfect health he/she is
expected to have. Continuing with the
example above, if this individual has an
HRQL score of 0.6 at age 60 and is expected
to live for 10 more years, the remaining
quality-adjusted life expectancy at age 60
is 0.63 10 = 6 QALYs.
For this study, individual-level EQ-5D
scores from theMEPSwere summarized by
race (black or white) and diabetes/VI status
(no diabetes/no VI, diabetes only, VI only,
and diabetes plus VI). Multivariate analyses
were conducted to estimate differences in
EQ-5D scores across the sample adjusting
for age, sex, and race. To calculate life
expectancy, life tables based on the general
U.S. population were used by which the
risk of mortality was adjusted by age, sex,
race, diabetes, and VI status. Following the
method outlined in Muennig and Gold
(10), we multiplied the total number of
person-years in each age category by the
age-specific EQ-5D score to get quality-
adjusted life expectancy. Differences in
quality-adjusted life expectancy by race
and diabetes/VI status represent the incre-
mental QALYs (i.e., marginally greater
years of optimal health) experienced by
whites relative to blacks.
All statistical analyses were performed
using SAS 9.2 (SAS Institute Inc., Cary,
NC). To account for the complex survey
design of the MEPS data, analyses were
completed with adjustments for sample
weights and design effects. The University
of Miami institutional review board re-
viewed and approved this study.
RESULTSdTable 1 presents the QALYs
and incremental QALYs among blacks and
whites by VI and diabetes status. For all
comparisons, whites were at an advantage
relative to blacks in terms of health status
and longevity (P , 0.05). In addition,
whites with neither VI nor diabetes had
the greatest number of years of optimal
health (31.6), whereas blacks living with
both conditions had the fewest years of op-
timal health (19.6). In terms of incremental
differences in QALYs, whites without dia-
betes or VI had 3.4 more years of optimal
health (more QALYs) than blacks without
diabetes or VI (95%CI 3.19–3.69).Whites
with diabetes only had 1.7 more QALYs
than blacks with diabetes (only) (0.87–
2.38), whereas whites with VI (only) had
4.3 more QALYs than blacks with VI
(only) (3.19–5.55). Finally, whites with
both diabetes and VI had 3.5 more
QALYs than blacks with both diabetes
and VI (1.26–5.97).
The relative advantage experienced
by whites with no diabetes/no VI com-
pared with whites with VI only was 0.9
QALYs (4.3 2 3.4). This relative advan-
tage completely disappears when com-
paring differences in incremental QALYs
between the no diabetes/no VI group to
the diabetes only group (1.723.4 =21.7).
The relative advantage experienced by
whites was the largest when comparing
having diabetes only with having diabetes
plus VI: 1.8 QALYs (3.5 2 1.7). These re-
sults are being driven by racial differences
in life expectancy. A separate analysis of the
mean EQ-5D scores alone showed that
whites are at an advantage in terms of
HRQL as they have higher EQ-5D scores
than blacks across all diabetes/VI compar-
isons, but the difference in EQ-5D between
blacks and whites is the same for diabetes
only as it is for VI only (for both compar-
isons whites had a mean EQ-5D score of
0.77, whereas blacks had an EQ-5D score
of 0.75).
CONCLUSIONSdThe relative ad-
vantage in QALYs experienced by whites
with no diabetes/no VI (3.4 QALYs) di-
minishes to 1.7 QALYs when comparing
whites with diabetes only to blacks with
diabetes only. This finding contributes to
existing evidence that the mortality gap
between whites and blacks with diabetes
has lessened and that more aggressive
treatment strategies targeting health dis-
parities among those with diabetes have
reduced the morbidity gap as well (11).
Thus, for diabetes only, the disparity
in disease burden between blacks and
whites is minimized relative to the other
diabetes/VI status comparisons. Once VI is
included along with diabetes, the gap re-
emerges, such that whites have 3.5 more
QALYs than blacks (more than double the
relative advantage experienced by whites
within the diabetes only comparison).
This is roughly the same as the relative
advantage experienced by whites with no
diabetes/no VI compared to blacks with
no diabetes/no VI.
The fact that among those with both
diabetes and VI the incremental QALYs are
actually less than the incremental QALYs
among those with VI only suggests that,
from a health and longevity perspective, it
is better to have both diabetes and VI as
opposed to VI alone if you are black. This is
likely the case given that black communi-
ties tend to have fewer resources, poorer
infrastructure, and fewer accommodations
for disabilities such as VI. These commu-
nity factors would explain why the relative
burden of diabetes plus VI is much greater
in blacks than the burden of diabetes alone.
This study possesses a number of
strengths, including the use of nationally
representative data, large sample size
(N = 2,639 visually impaired), and the op-
portunity to highlight subgroup analyses
by diabetes and VI status across two race
groups. But it is also limited by the use of
cross-sectional data, self-reported diabetes,
and VI status, and the onset and treatability
of diabetes and VI are not known. In addi-
tion, we do not address the presence of
other diseases like cancer or heart disease
in our comparison groups. We adjusted
analyses by age, sex, race, and diabetes/VI
status, but not by other characteristics. This
provides us with a sense of the overall
burden of disease given the underlying
Table 1dQALYs and incremental QALYs among blacks and whites by VI and diabetes status
Race No diabetes/no VI (N = 35,226) Diabetes only (N = 2,398) VI only (N = 2,181) Diabetes plus VI (N = 427)
Black 28.19 (27.93–28.46) 24.12 (23.41–24.84) 22.64 (21.46–23.85) 19.63 (17.36–21.60)
White 31.63 (31.46–31.79) 25.77 (25.41–26.10) 26.94 (26.56–27.38) 23.09 (22.02–24.16)
Incremental QALYs 3.44* (3.19–3.69) 1.65* (0.87–2.38) 4.31* (3.19–5.55) 3.46* (1.26–5.97)
Values in parentheses are 95%CI. Sample sizes vary betweenN = 106 for blacks with both diabetes and VI andN = 28,603 for whites with no impairment. Incremental
QALYs reflect the difference in QALYs between whites and blacks such that higher values reflect greater QALYs among whites. *Statistically significant (P , 0.05).
care.diabetesjournals.org DIABETES CARE, VOLUME 35, AUGUST 2012 1693
McCollister and Associates
socioeconomic characteristics of the co-
hort and allows us to capture the race-
associated variation in characteristics
such as income and education within the
pathway to triple disadvantage. Finally, in
order to preserve sample size, we col-
lapsed different categories of VI into one
measure of any VI. Although this reduces
the precision of our estimates (potentially
underestimating the full impact of having
VI), ,1% of the sample reported having
severe VI (i.e., blindness).
Future studies should identify other
conditions that potentially synergize with
visual impairment to produce greater
overall disability and to determine how
diabetes and VI fit into the cascade of
comorbidities (12). Although some gains
have been made in reducing racial dispar-
ities in morbidity and mortality due to di-
abetes, these gains may have done little to
alleviate disadvantages within black com-
munities. For instance, diabetes can lead
to VI, and black communities may be less
likely to accommodate those who suffer
from this condition (4,5). Discriminatory
policies of the past, such as redlining in
black communities, have led to concentra-
tions of poverty and higher than average
levels of stress and social disorganization
in these communities. This, in turn, has
been linked to lower levels of social support
and social capital (13). Healthcare reform
in the U.S. seems poised to further address
racial health disparities. The recently
passed Affordable Care Act provides $11
billion to expand community health cen-
ters over the next 5 years. These centerswill
target medically underserved and disad-
vantaged neighborhoods throughout the
U.S. to provide better access to preven-
tive and primary care services, as well
as to sustain and create jobs. Such
efforts may improve the health and
living conditions within black communi-
ties and may be the key to truly reducing
racial disparities in health and longevity
associated with a number of health
conditions and disabilities. However, it
is also important to consider the commu-
nity context itself if health disparities are to
be eliminated.
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